Albumin fusion proteins
US7189690B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2004 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Nov 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating or preventing diseases, disorders or conditions related to diabetes mellitus using albumin fusion proteins of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.